Lighthouse Trust
9
2
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
PathToScale: The PERSIST Trial
Role: collaborator
PathToScale: An Implementation Evaluation
Role: collaborator
The DTG-SWITCH Study: Longitudinal Analysis of Virologic Failure and Drug Resistance at and After Switching to Dolutegravir-based First-line ART
Role: collaborator
Driving Reduced AIDS-associated Meningo-encephalitis Mortality
Role: collaborator
Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
Role: collaborator
Evaluation of Pre-Exposure Prophylaxis for High Risk Adolescent Girls and Young Women
Role: lead
Assessing the Effectiveness and Feasibility of Voluntary Assisted Partner Notification Services
Role: lead
The Lighthouse Tenofovir Cohort Study
Role: lead
Promoting Uptake and Retention of Option B+ in Malawi
Role: lead
All 9 trials loaded